PAA 0.00% 20.5¢ pharmaust limited

Ann: Appointment of Non-Executive Director, page-12

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 390 Posts.
    lightbulb Created with Sketch. 723
    "US exposure in hiring top US talent in marketing"
    Wholly agree. US networks are prime marketing targets - and a hugely valuable word-of mouth marketing strategy - especially from trusted and respected sources - like an industry-experienced exec with street cred - and a specialist in 'market and product assessments, market sizing and
    forecasting, pre-launch preparation and launch and marketing of pharmaceutical products for biopharmaceutical companies
    '.

    Yes.

    "Mayne Pharma has a full service contract development and manufacturing organisations (CDMO) specialising in novel oral and topical dose forms providing pharmaceutical development, analytical testing and commercial manufacturing to clients worldwide, with expertise in drug discovery and development, clinical trials supply and commercial manufacture from our single South Australian site."

    Local knowledge, global experience, pharmacy qualifications, marketing specialist etc. = a seriously credentialled outstanding addition to the team.


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.